Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: Improving the efficiency of cell line generation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Transfectants with a wide range of cellular phenotypes are obtained during the process of cell line generation. For the successful manufacture of a therapeutic protein, a means is required to identify a cell line with desirable growth and productivity characteristics from this phenotypically wide‐ranging transfectant population. This identification process is on the critical path for first‐in‐human studies. We have stringently examined a typical selection strategy used to isolate cell lines suitable for cGMP manufacturing. One‐hundred and seventy‐five transfectants were evaluated as they progressed through the different assessment stages of the selection strategy. High producing cell lines, suitable for cGMP manufacturing, were identified. However, our analyses showed that the frequency of isolation of the highest producing cell lines was low and that ranking positions were not consistent between each assessment stage, suggesting that there is potential to improve upon the strategy. Attempts to increase the frequency of isolation of the 10 highest producing cell lines, by in silico analysis of alternative selection strategies, were unsuccessful. We identified alternative strategies with similar predictive capabilities to the typical selection strategy. One alternate strategy required fewer cell lines to be progressed at the assessment stages but the stochastic nature of the models means that cell line numbers are likely to change between programs. In summary, our studies illuminate the potential for improvement to this and future selection strategies, based around use of assessments that are more informative or that reduce variance, paving the way to improved efficiency of generation of manufacturing cell lines. © 2010 American Institute of Chemical Engineers Biotechnol. Prog., 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Stochastic mRNA Synthesis in Mammalian Cells
Raj, A., Peskin, C. S., Tranchina, D., Vargas, D. Y., & Tyagi, S. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040309 · Cited by 1,737
Smales, C. M., Dinnis, D. M., Stansfield, S. H., Alete, D., Sage, E. A., Birch, J. R., Racher, A. J., Marshall, C. T., & James, D. C. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20272 · Cited by 119
Self-citationBenton, T., Chen, T., McEntee, M., Fox, B., King, D., Crombie, R., Thomas, T. C., & Bebbington, C. (2002) · Cytotechnology · doi:10.1023/a:1021141712344 · Cited by 98
Kennard, M. L., Goosney, D. L., Monteith, D., Zhang, L., Moffat, M., Fischer, D., & Mott, J. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22406 · Cited by 52 · cited 1×
“A viable alternative to using integration site as a predictive marker may be to utilize site-specific integration to target the transgene to a site associated with stable expression.(27,28)”
Background
Cited by
Kelly, P. S., Breen, L., Gallagher, C., Kelly, S., Henry, M., Lao, N. T., Meleady, P., O'Gorman, D., Clynes, M., & Barron, N. (2015) · Biotechnology Journal · doi:10.1002/biot.201500101 · Cited by 49
Harraghy, N., Regamey, A., Girod, P.-A., & Mermod, N. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.04.004 · Cited by 37
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
Self-citationMaralingannavar, V., Shenoy, B. R., Hazarika, J., Unnikrishnan, D., Prabhu, A., Maity, S., & Gadgil, M. (2018) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.5635 · Cited by 2
Metadata
- Authors
- Porter, A. J., Racher, A. J., Preziosi, R., & Dickson, A. J.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2010-04-22
- Volume
- 26
- Issue
- 5
- Pages
- 1455-1464
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2127582347
- Cited by
- 71
- References
- 5
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: Improving the efficiency of cell line generation. https://app.cochat.ai/papers/10.1002/btpr.443
- The paper
- Porter, A. J., Racher, A. J., Preziosi, R., & Dickson, A. J. (2010). Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: Improving the efficiency of cell line generation. Biotechnology Progress. https://doi.org/10.1002/btpr.443
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.